Nasdaq · CIK 0001817760
SMTK SmartKem, Inc.
Insider trading from SEC Form 4. Last filing Sep 25, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at SmartKem, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 16 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | Joseph Christopher Lizzio owner | GGift Common Stock | -150,000 | $0.00 | $0 | 419,000 | Sep 25, 2025 |
| Sep 3, 2025 | Steven Denbaars director | AGrant or award Stock Option (right to buy)derivative | +22,466 | $0.00 | $0 | 22,466 | Sep 12, 2025 |
| Sep 3, 2025 | Melisa Denis director | AGrant or award Stock Option (right to buy)derivative | +22,466 | $0.00 | $0 | 22,466 | Sep 5, 2025 |
| Sep 3, 2025 | Ian Jenks Chairman & CEO | AGrant or award Stock Option (right to buy)derivative | +160,005 | $0.00 | $0 | 160,005 | Sep 5, 2025 |
| Sep 3, 2025 | Barbra Keck Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +71,077 | $0.00 | $0 | 71,077 | Sep 5, 2025 |
| Sep 3, 2025 | Sriram Krishnamurthy Peruvemba director | AGrant or award Stock Option (right to buy)derivative | +22,466 | $0.00 | $0 | 22,466 | Sep 5, 2025 |
| Sep 3, 2025 | Klaas de Boer director | AGrant or award Stock Option (right to buy)derivative | +22,466 | $0.00 | $0 | 22,466 | Sep 5, 2025 |
| May 28, 2025 | Beverley Brown Chief Scientist | AGrant or award Stock Option (right to Buy)derivative | +33,741 | $0.00 | $0 | 33,741 | May 28, 2025 |
| May 28, 2025 | Steven Denbaars director | AGrant or award Stock Option (right to Buy)derivative | +23,915 | $0.00 | $0 | 23,915 | May 28, 2025 |
| May 28, 2025 | Melisa Denis director | AGrant or award Stock Option (right to Buy)derivative | +23,915 | $0.00 | $0 | 23,915 | May 28, 2025 |
| May 28, 2025 | Ian Jenks Chairman & CEO | AGrant or award Stock Option (right to Buy)derivative | +170,320 | $0.00 | $0 | 170,320 | May 28, 2025 |
| May 28, 2025 | Barbra Keck Chief Financial Officer | AGrant or award Stock Option (right to Buy)derivative | +75,660 | $0.00 | $0 | 75,660 | May 28, 2025 |
| May 28, 2025 | Simon Ogier Chief Technology Officer | AGrant or award Stock Option (right to Buy)derivative | +77,656 | $0.00 | $0 | 77,656 | May 28, 2025 |
| May 28, 2025 | Sriram Krishnamurthy Peruvemba director | AGrant or award Stock Option (right to Buy)derivative | +23,915 | $0.00 | $0 | 23,915 | May 28, 2025 |
| May 28, 2025 | Klaas de Boer director | AGrant or award Stock Option (right to Buy)derivative | +23,915 | $0.00 | $0 | 23,915 | May 28, 2025 |
| May 28, 2025 | Jonathan Watkins Chief Operating Officer | AGrant or award Stock Option (right to Buy)derivative | +131,745 | $0.00 | $0 | 131,745 | May 28, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Beverley BrownChief Scientist
- Steven Denbaarsdirector
- Melisa Denisdirector
- Ian JenksChairman & CEO
- Barbra KeckChief Financial Officer
- Joseph Christopher Lizzioowner
- Simon OgierChief Technology Officer
- Sriram Krishnamurthy Peruvembadirector
- Jonathan WatkinsChief Operating Officer
- Klaas de Boerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.